Conference Call Scheduled for Wednesday, February 5 at 4:30 p.m. Eastern Time SAN DIEGO, Jan. 29, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will release financial results for the fourth quarter and year-end 2024 after the market close on Wednesday, February 5, 2025.The company will host a conference call to discuss fi ...

FREMONT, Calif., Jan. 29, 2025 /PRNewswire/ -- Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended December 29, 2024 (the "December 2024 quarter").Highlights for the December 2024 quarter were as follows: Revenue of $4.38 billion. U.S. GAAP gross margin of 47.4%, U.S. GAAP operating income as a percentage of revenue of 30.5%, and U.S. GAAP diluted EPS of $0.92. Non-GAAP gross margin of 47.5%, non-GAAP operating income as a percentage of rev ...

CALGARY, AB, Jan. 29, 2025 /PRNewswire/ - Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) today announced its fourth-quarter results, including revenues of $3.9 billion, diluted earnings per share (EPS) of $1.28 and core adjusted combined diluted EPS1 of $1.29.Fourth-quarter 2024 results Revenues increased by three percent to $3.9 billion from $3.8 billion in Q4 2023 Reported operating ratio (OR) decreased by 210 basis points to 59.7 percent from 61.8 percent in Q4 2023 Core adjusted combined OR1 d ...

SOUTHERN PINES, N.C., Jan. 29, 2025 /PRNewswire/ -- First Bancorp (the "Company") (NASDAQ - FBNC), the parent company of First Bank, reported unaudited fourth quarter and full year earnings today.  The Company announced net income of $3.6 million, or $0.08 diluted earnings per share ("EPS"), for the three months ended December 31, 2024 compared to $18.7 million, or $0.45 diluted earnings per common share, for the three months ended September 30, 2024 ("linked quarter") and $29.7 million, or $0.72 diluted ea ...

SCOTTSDALE, Ariz., Jan. 29, 2025 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, will release fourth quarter and full year 2024 financial results after the close of the New York Stock Exchange on Thursday, February 20, 2025. A conference call and simultaneous webcast to discuss the results will be held on Thursday, February 20, 2025 a ...

Corning (GLW -2.44%) stock is losing ground Wednesday despite an initial bullish surge early in the day's trading. The company's share price was down 2.4% as of 3:45 p.m. ET, but it had been up as much as 8% earlier in the session.Corning stock jumped early thanks to better-than-expected fourth-quarter results and forward guidance, but it lost ground in response to a pair of bearish catalysts. Despite the strong start, uncertainty surrounding the new DeepSeek R1 artificial intelligence (AI) model and the Fe ...

The Company Generates Record Annual Revenue of $522.3 Million, 6th Consecutive Quarter of Positive Free Cash Flow at $5.9 Million, With Trailing Free Cash Flow Totaling $22.0 MillionThe Company's Flagship Cabana Club Loyalty Program Has Now Reached 5.32 Million Members Worldwide Including Over 76,000 ELITE MembersThis news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated August 31, 2023, to its short form base shelf prospectus dated August 3, 2023 ...

As previously reported1, the study met the primary efficacy endpoint for the treatment with lanifibranor 800mg demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy (1H-MRS) following 24 weeks of treatment in patients with MASLD and T2DA significantly higher proportion of patients achieved a greater than 30% liver triglyceride reduction as well as MASLD resolution with lanifibranor compared to placeboLanifibranor treatment significantly improved both hepatic and per ...

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: Many riders prefer the convenience of ride-sharing services over the lower fares of public transportation. New research led by the University of Michigan helps show why modest surcharges to shared rides won't change transit usage. Credit: Miki Tsuchiya Research led by the University of Michigan has arrived at a surprisingly unsu ...

Microsoft will report its second-quarter earnings for fiscal year 2025 Wednesday as questions over multibillion-dollar spending on AI continue to mount, spurred by DeepSeek’s shock to the US stock market just days ago.Wall Street expects $3.11 in earnings per share and revenue of $68.9bn, compared with $2.93 a share and revenue of $62bn for the same period a year earlier.Shares in the company, worth a total of $3.28tn, are up roughly 8% over the past 12 months, even as it has poured capital investment into ...